Author

Anna Marie Celina Garfin

Observed names: A M Celina Garfin, A. Garfin, A. M. C. G. Garfin, A. M. C. Garfin, A.M.C. Garfin, AMC Garfin, Anna M. C. Garfin, Anna Marie Celina G. Garfin, Anna Marie Celina G. Garfin, Anna Marie Celina G.Garfin, Anna Marie Celina Gonzales Garfin, Anna Marie CelinaG Garfin, Anna-Marie C. G. Garfin, Anna-Marie Celine Garfin, AnnaMarie Celina Garfin, C. Garfin, Celina Garfin, Garfin, A.M.C.

Institution: Department of Health

Observed institutions: Centers for Disease Control and Prevention, Department of Health, Lung Center of the Philippines, United States Agency for International Development, Tropical Disease Foundation, World Health Organization - Philippines

ORCID: 0000-0003-3793-2429

Observed ORCID: 0000-0003-3793-2429

OpenAlex ID: A5070496299

Factors Associated with Loss to Follow-up during Treatment for Multidrug-Resistant Tuberculosis, the Philippines, 2012–2014

2016 · Thelma E. Tupasi, Anna Marie Celina G. Garfin, et al. · Emerging infectious diseases · 92

Bringing state-of-the-art diagnostics to vulnerable populations: The use of a mobile screening unit in active case finding for tuberculosis in Palawan, the Philippines

2017 · Fukushi Morishita, Anna Marie Celina Gonzales Garfin, et al. · PLoS ONE · 66

The impact of COVID-19 and the restoration of tuberculosis services in the Western Pacific Region

2020 · Chen-Yuan Chiang, Tauhid Islam, et al. · European Respiratory Journal · 50

Patterns and predictors of co-morbidities in Tuberculosis: A cross-sectional study in the Philippines

2020 · Laura V. White, Tansy Edwards, et al. · Scientific Reports · 42

Cost-effectiveness of bedaquiline, pretomanid and linezolid for treatment of extensively drug-resistant tuberculosis in South Africa, Georgia and the Philippines

2021 · Gabriela Beatriz Gomez, Mariana Siapka, et al. · BMJ Open · 35

The tuberculosis profile of the Philippines, 2003–2011: advancing DOTS and beyond

2013 · Rosalind Vianzon, Anna Marie Celina Garfin, et al. · Western Pacific surveillance response journal · 35

High TB burden and low notification rates in the Philippines: The 2016 national TB prevalence survey

2021 · Mary Ann D. Lansang, Marissa M. Alejandria, et al. · PLoS ONE · 31

Effectiveness of digital adherence technologies in improving tuberculosis treatment outcomes in four countries: a pragmatic cluster randomised trial protocol

2023 · Degu Jerene, Jens Levy, et al. · BMJ Open · 27

Expansion of social protection is necessary towards zero catastrophic costs due to TB: The first national TB patient cost survey in the Philippines

2022 · Jhiedon L. Florentino, Rosa Mia L. Arao, et al. · PLoS ONE · 26

Diagnostic accuracy of chest X-ray interpretation for tuberculosis by three artificial intelligence-based software in a screening use-case: an individual patient meta-analysis of global data

2022 · Sandra V. Kik, Sifrash M. Gelaw, et al. · medRxiv · 24

Effect of digital adherence technologies on treatment outcomes in people with drug-susceptible tuberculosis: four pragmatic, cluster-randomised trials

2025 · Degu Jerene, Kristian van Kalmthout, et al. · The Lancet · 23

Association of diabetes, smoking, and alcohol use with subclinical-to-symptomatic spectrum of tuberculosis in 16 countries: an individual participant data meta-analysis of national tuberculosis prevalence surveys

2023 · Yohhei Hamada, Matteo Quartagno, et al. · EClinicalMedicine · 22

The challenges of the Philippines' social health insurance programme in the era of Universal Health Coverage

2018 · A. Querri, A. Ohkado, et al. · Public Health Action · 22

Behavioural barriers and perceived trade-offs to care-seeking for tuberculosis in the Philippines

2020 · Emily Zimmerman, Jana Smith, et al. · Global Public Health · 21

Multidrug-resistant tuberculosis patients' views of interventions to reduce treatment loss to follow-up

2016 · T. Tupasi, A. M. C. G. Garfin, et al. · The International Journal of Tuberculosis and Lung Disease · 16

Patterns of non-communicable comorbidities at start of tuberculosis treatment in three regions of the Philippines: The St-ATT cohort

2021 · Sharon E. Cox, Tansy Edwards, et al. · PLOS Global Public Health · 14

Feasibility and acceptability of the smart pillbox and medication label with differentiated care to support person-centered tuberculosis care among ASCENT trial participants – A multicountry study

2024 · Amare W. Tadesse, Andrew Mganga, et al. · Frontiers in Public Health · 13

High rates of human immunodeficiency virus and drug resistance in tuberculosis patients in Manila, Philippines

2017 · Toshio Hattori, MariettaB Solante, et al. · Biomedical and Biotechnology Research Journal (BBRJ) · 13

Adherence trajectory as an on-treatment risk indicator among drug-resistant TB patients in the Philippines

2022 · S Huddart, DM Geocaniga-Gaviola, et al. · PLoS ONE · 12

Optimizing diagnostic networks to increase patient access to TB diagnostic services: Development of the diagnostic network optimization (DNO) approach and learnings from its application in Kenya, India and the Philippines

2023 · Heidi Albert, Sidharth Rupani, et al. · PLoS ONE · 10

Cost of TB prevention and treatment in the Philippines in 2017

2022 · T. P. J. Capeding, J. D. Rosa, et al. · The International Journal of Tuberculosis and Lung Disease · 10

Use of GeneXpert and the role of an expert panel in improving clinical diagnosis of smear-negative tuberculosis cases

2019 · Jovilia Abong, Victoria Dalay, et al. · PLoS ONE · 10

Impact of heteroresistance on treatment outcomes of people with drug-resistant TB

2024 · R. Crowder, M. Kato-Maeda, et al. · IJTLD OPEN · 9

Low prevalence of fluoroquinolone resistance among patients with tuberculosis in the Philippines: results of a national survey

2018 · Dodge R. Lim, Anna S. Dean, et al. · European Respiratory Journal · 9

Enhancing tuberculosis patient detection and care through community volunteers in the urban poor, The Philippines

2017 · A. Querri, A. Ohkado, et al. · Public Health Action · 9

Works count: 54

Citation count: 723

H-index: 15

I10-index: 22